Private Sector Testing Avalonlabs launched COVID testing for the private sector in 2020, signaling capability to provide diagnostic services outside traditional public health channels. This creates an opportunity to pursue contracts with employers, corporate health programs, and community testing initiatives, offering scalable testing capacity and private sector focused service models.

Mid-size Lab Scale With 201-500 employees and revenue in the 1–10M range, Avalon operates as a mid-sized laboratory capable of handling higher-volume testing and lab services. This profile aligns with opportunities to offer volume-based contracts, managed service offerings, or equipment and automation solutions to similarly scaled clinics and labs.

Nordson Synergy Historically, Avalon was acquired by the Nordson MEDICAL division of Nordson Corporation, indicating a legacy connection to Nordson's customer base and product ecosystem. This presents a path for cross sell and integration opportunities into Nordson's medical device and lab equipment portfolio.

US Market Footprint Based in the United States with a defined regional footprint, Avalon can target US based employers, manufacturers, and healthcare providers seeking domestic diagnostic services, PPE supply, or lab equipment integration, leveraging local regulatory familiarity and agile deployment.

Private Sector Expansion The private sector COVID testing initiative points to a growth channel beyond hospitals and reference labs. Sales opportunities include partnerships with employers for regular test programs, occupational health services, and private clinics seeking outsourced testing capabilities.